PPT-COVID-19 vaccines Regulatory Status Update 25 January 2021 Dr B Semete-Makokotlela SAHPRA

25 January 2021 Dr B SemeteMakokotlela SAHPRA CEO Vaccine applications submitted to SAHPRA Vaccine developer Name Regulatory status outside SA Application at SAHPRA Status at SAHPRA Janssen. 1-19 VACCINESAn Advisory Committee Statement ACSNational Advisory Committee on Immunization NACIRecommendations on the use of COVID-19 VaccinesPublished July22 20212RECOMMENDATIONS ON THE USE OF COVID on following dates in 2021 July 2021 There will be supplementary data update when IEF receives additional data submissions after those update dates above The completion of each Among Your Patients. Tips for the Healthcare Team. Developed by:. CDC COVID-19 Response . Vaccine Task Force. January 2021. Presentation Overview. COVID-19 vaccines. mRNA vaccine technology. Vaccine safety monitoring. October . 2021. Coronaviruses in General. Coronavirus is a name derived from the Latin "corona," meaning crown.. The viral envelope under the electron microscope looks "crownlike" due to the small bulbar projections formed by the viral spike proteins.. Immunizations and Vaccines. What is a Vaccine?. Vaccine = Immunization. Weakened or killed virus or bacteria, or lab made protein. What is in a Vaccine?. Today’s vaccines use only the ingredients they need to be as safe and effective as possible.. Myself, the webinar planning group, content reviewers, and CME application reviewers, do not have a relevant financial relationship with the manufacturers of commercial products and/or providers of commercial services discussed in this CME activity.. 12/15/2021. Today’s Speaker. Gregory Schrank, MD MPH. Dr. Greg Schrank attended medical school at the Lewis Katz School of Medicine at Temple University in Philadelphia. He went on to complete Internal Medicine residency training at the NYU School of Medicine, where he also served as a chief medical resident, followed by a fellowship in Infectious Diseases at Beth Israel Deaconess Medical Center/Harvard Medical School. While there, he completed additional fellowship training in infection control and hospital epidemiology. After fellowship, Dr. Schrank joined the faculty at the University of Maryland School of Medicine as an Assistant Professor of Medicine in the Division of Infectious Diseases. He sees patients at the R Adams Cowley Shock Trauma Center and serves as an Associate Hospital Epidemiologist for the University of Maryland Medical Center. During the COVID-19 pandemic, he served as an Incident Commander for the COVID-19 response at the University of Maryland Medical Center during the Spring and Fall surges of 2020 and more recently as a subject matter expert for University of Maryland Medical System’s vaccination efforts. . Dr B Semete-Makokotlela. SAHPRA CEO. 21 July . 2021. Contents. COVID-19 vaccines updates. Vaccines authorization process. Ivermectin update. COVID-19 vaccines updates. Pre-Submission Meetings between SAHPRA and Applicants. Plantation project in . Gurgoan. , . Noida, Pune, Bangalore, Chennai, . Coimbatore . & . Hyderabad. 01. 02. 03. 04. 05. 06. TABLE OF . CONTENTS. EXECUTIVE. SUMMARY. OBJECTIVES. STATUS UPDATE. PICTURES FROM THE GROUND. Matthew Golden, MD, MPH. Professor of Medicine, University of Washington. Director, PHSKC HIV/STD Program. Director, UW Center for AIDS and STD. COVID-19 Clinical Update. I-TECH Videoconference . February 8, 2021 . 03 February 2021. Dr B Semete. Contents. COVID-19 vaccines. Ivermectin. access program. Summary of the most advanced vaccines in development. Vaccine applications submitted to SAHPRA. Vaccine developer. Disclosure. . This presentation has been created using the . CDC’s COVID-19 Vaccine Information for Community-Based Organizations. , as well as information included in the CDC’s frequently asked questions section. The sources will be included at the end of this presentation. . Tennessee. . Provider. . Update. Paul. . E. Petersen,. . PharmD. . |. . October. . 8,. . 2021. Objectives. Review. . TN. . COVID-19. . vaccine. . uptake. . metrics. Highlight. . COVID-19. HEALTH: SAHPRA 2020/21 . ANNUAL REPORT. NOVEMBER 2021. PRESENTATION OUTLINE. Executive Summary. Overall Performance . Response to COVID-19. Performance Information per Programme:. Programme 1: Administration .